A prospective, non interventional, trial evaluating the diagnostic accuracy of FBLN3 for Mesothelioma pleural effusions

Administered By

Surgery, Cardiovascular and Thoracic Surgery

Awarded By

New York University School of Medicine

Contributors

Harpole Jr., David Harold Principal Investigator

Start/End

September 1, 2021 - March 31, 2022